Xsphera Biosciences
Xsphera Biosciences Inc. is a revenue-stage biotechnology company specializing in oncology drug development by bridging the translational gap between animal models and human clinical trials. Their patented ex vivo platform uses fresh human tumor tissue to create spheroids that preserve the unique tumor microenvironment of each patient, enabling accurate assessment of therapeutic efficacy across various cancer indications and drug modalities. This platform integrates multi-omic response data with an AI-powered cloud analytics system to reveal mechanisms of action and resistance, supporting drug development teams with study design, execution, and analysis. Xsphera's approach addresses the high failure rate of oncology drugs in clinical trials by providing predictive insights before trials, thus reducing wasted resources and improving patient care options. The company operates with a clinical network across North America and offers extensive data integration and visualization capabilities to accelerate decision-making in oncology therapeutics development.
Xsphera Biosciences
Xsphera Biosciences Inc. is a revenue-stage biotechnology company specializing in oncology drug development by bridging the translational gap between animal models and human clinical trials. Their patented ex vivo platform uses fresh human tumor tissue to create spheroids that preserve the unique tumor microenvironment of each patient, enabling accurate assessment of therapeutic efficacy across various cancer indications and drug modalities. This platform integrates multi-omic response data with an AI-powered cloud analytics system to reveal mechanisms of action and resistance, supporting drug development teams with study design, execution, and analysis. Xsphera's approach addresses the high failure rate of oncology drugs in clinical trials by providing predictive insights before trials, thus reducing wasted resources and improving patient care options. The company operates with a clinical network across North America and offers extensive data integration and visualization capabilities to accelerate decision-making in oncology therapeutics development.